NPFFR2 Deletion Improves Hypothalamic Insulin Sensitivity and Metabolic Outcomes in Mice With Diet-induced Obesity
Endocrinology · 2025
DOI: 10.1210/endocr/bqaf157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, 2025. Verfasst von Hsiang-Ting Hsu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Chang Gung University, Taoyuan 33302, Taiwan. Hauptthemen laut MEDLINE: Insulin Resistance, Obesity, Hypothalamus, Receptors, Neuropeptide. Die Arbeit nennt 31 Literaturangaben. Gefördert von: National Science and Technology Council.
Abstract (Originalsprache)
Neuropeptide FF receptor 2 (NPFFR2) is a key regulator of energy homeostasis, influencing feeding behavior, insulin sensitivity, and lipid metabolism. This study investigates the metabolic consequences of Npffr2 deletion in a mouse model of diet-induced obesity. Wild-type and Npffr2 knockout mice were fed a high-fat, high-sucrose diet to induce obesity, followed by comprehensive metabolic assessments. Npffr2 knockout mice exhibited reduced food intake, accompanied by significant downregulation of hypothalamic orexigenic neuropeptides agouti-related peptide and neuropeptide Y. Enhanced energy expenditure was observed in knockout mice, as evidenced by increased thermogenic capacity, elevated uncoupling protein 1 expression in brown adipose tissue, and improved core temperature maintenance under cold exposure. Lipid metabolism was also improved, with reduced hepatic and adipose lipid accumulation and lower circulating triglyceride and non-esterified fatty acid levels. Molecular analyses revealed increased AKT phosphorylation in the hypothalamus and skeletal muscle, along with downregulation of protein tyrosine phosphatase 1B in the mediobasal hypothalamus, indicating improved central and peripheral insulin signaling. Here, we demonstrated that NPFFR2 plays a critical role in obesity-associated energy regulation, lipid accumulation, and insulin resistance. These findings highlight NPFFR2 as a potential therapeutic target for obesity and related metabolic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
- School of Respiratory Therapy & Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110301, Taiwan.
- Division of Pulmonary Medicine, Department of Internal Medicine, Taipei Medical University Hospital, Taipei 110301, Taiwan.
- Graduate Institute of Metabolism and Obesity Sciences, College of Nutrition & TMU Research Center for Digestive Medicine, Taipei Medical University, Taipei 110301, Taiwan.
- Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
- Department of Natural Sciences, Oregon Institute of Technology, Klamath Falls, OR 97601, USA.
ORCID-Profile: Ya-Tin Lin
Förderung
- National Science and Technology Council
Zitieren
APA
Hsu, H. T., Hsu, C. C., Tsai, S. C., Chen, J. C., Li, H. Y., & Lin, Y. T. (2025). NPFFR2 Deletion Improves Hypothalamic Insulin Sensitivity and Metabolic Outcomes in Mice With Diet-induced Obesity. Endocrinology. https://doi.org/10.1210/endocr/bqaf157
Vancouver
Hsu HT, Hsu CC, Tsai SC, Chen JC, Li HY, Lin YT. NPFFR2 Deletion Improves Hypothalamic Insulin Sensitivity and Metabolic Outcomes in Mice With Diet-induced Obesity. Endocrinology. 2025. doi:10.1210/endocr/bqaf157
BibTeX
@article{Hsu2025,
author = {Hsu, Hsiang-Ting and Hsu, Chun-Chun and Tsai, Sze-Chi and Chen, Jin-Chung and Li, Hui-Yun and Lin, Ya-Tin},
title = {NPFFR2 Deletion Improves Hypothalamic Insulin Sensitivity and Metabolic Outcomes in Mice With Diet-induced Obesity},
journal = {Endocrinology},
year = {2025},
doi = {10.1210/endocr/bqaf157}
}
EUVIMED